Literature DB >> 22493452

Polythiophenes inhibit prion propagation by stabilizing prion protein (PrP) aggregates.

Ilan Margalith1, Carlo Suter, Boris Ballmer, Petra Schwarz, Cinzia Tiberi, Tiziana Sonati, Jeppe Falsig, Sofie Nyström, Per Hammarström, Andreas Aslund, K Peter R Nilsson, Alice Yam, Eric Whitters, Simone Hornemann, Adriano Aguzzi.   

Abstract

Luminescent conjugated polymers (LCPs) interact with ordered protein aggregates and sensitively detect amyloids of many different proteins, suggesting that they may possess antiprion properties. Here, we show that a variety of anionic, cationic, and zwitterionic LCPs reduced the infectivity of prion-containing brain homogenates and of prion-infected cerebellar organotypic cultured slices and decreased the amount of scrapie isoform of PrP(C) (PrP(Sc)) oligomers that could be captured in an avidity assay. Paradoxically, treatment enhanced the resistance of PrP(Sc) to proteolysis, triggered the compaction, and enhanced the resistance to proteolysis of recombinant mouse PrP(23-231) fibers. These results suggest that LCPs act as antiprion agents by transitioning PrP aggregates into structures with reduced frangibility. Moreover, ELISA on cerebellar organotypic cultured slices and in vitro conversion assays with mouse PrP(23-231) indicated that poly(thiophene-3-acetic acid) may additionally interfere with the generation of PrP(Sc) by stabilizing the conformation of PrP(C) or of a transition intermediate. Therefore, LCPs represent a novel class of antiprion agents whose mode of action appears to rely on hyperstabilization, rather than destabilization, of PrP(Sc) deposits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22493452      PMCID: PMC3365923          DOI: 10.1074/jbc.M112.355958

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities.

Authors:  Hugo E. Gottlieb; Vadim Kotlyar; Abraham Nudelman
Journal:  J Org Chem       Date:  1997-10-17       Impact factor: 4.354

Review 2.  Transmission of prions.

Authors:  C Weissmann; M Enari; P-C Klöhn; D Rossi; E Flechsig
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

3.  Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes.

Authors:  K Peter R Nilsson; Andreas Aslund; Ina Berg; Sofie Nyström; Peter Konradsson; Anna Herland; Olle Inganäs; Frantz Stabo-Eeg; Mikael Lindgren; Gunilla T Westermark; Lars Lannfelt; Lars N G Nilsson; Per Hammarström
Journal:  ACS Chem Biol       Date:  2007-08-03       Impact factor: 5.100

4.  An analytical solution to the kinetics of breakable filament assembly.

Authors:  Tuomas P J Knowles; Christopher A Waudby; Glyn L Devlin; Samuel I A Cohen; Adriano Aguzzi; Michele Vendruscolo; Eugene M Terentjev; Mark E Welland; Christopher M Dobson
Journal:  Science       Date:  2009-12-11       Impact factor: 47.728

5.  Physical properties of the Creutzfeldt-Jakob disease agent.

Authors:  T K Sklaviadis; L Manuelidis; E E Manuelidis
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

6.  Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner.

Authors:  Jan Kranich; Nike Julia Krautler; Jeppe Falsig; Boris Ballmer; Shulei Li; Gregor Hutter; Petra Schwarz; Rita Moos; Christian Julius; Gino Miele; Adriano Aguzzi
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

7.  Stabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptide.

Authors:  Deborah J Tew; Stephen P Bottomley; David P Smith; Giuseppe D Ciccotosto; Jeffrey Babon; Mark G Hinds; Colin L Masters; Roberto Cappai; Kevin J Barnham
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

8.  Detergent-like interaction of Congo red with the amyloid beta peptide.

Authors:  Christofer Lendel; Benedetta Bolognesi; Anna Wahlström; Christopher M Dobson; Astrid Gräslund
Journal:  Biochemistry       Date:  2010-02-23       Impact factor: 3.162

9.  Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes.

Authors:  E Terzi; G Hölzemann; J Seelig
Journal:  J Mol Biol       Date:  1995-10-06       Impact factor: 5.469

10.  Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters.

Authors:  M Pocchiari; S Schmittinger; C Masullo
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

View more
  18 in total

1.  Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway.

Authors:  Sofie Nyström; Rajesh Mishra; Simone Hornemann; Adriano Aguzzi; K Peter R Nilsson; Per Hammarström
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Developing Therapeutics for PrP Prion Diseases.

Authors:  Kurt Giles; Steven H Olson; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 3.  Amyloid fibril polymorphism: a challenge for molecular imaging and therapy.

Authors:  M Fändrich; S Nyström; K P R Nilsson; A Böckmann; H LeVine; P Hammarström
Journal:  J Intern Med       Date:  2018-02-19       Impact factor: 8.989

Review 4.  Prion-Like Propagation of Post-Translationally Modified Tau in Alzheimer's Disease: A Hypothesis.

Authors:  Shweta Kishor Sonawane; Subashchandrabose Chinnathambi
Journal:  J Mol Neurosci       Date:  2018-07-07       Impact factor: 3.444

Review 5.  Therapeutic development of polymers for prion disease.

Authors:  Kenta Teruya; Katsumi Doh-Ura
Journal:  Cell Tissue Res       Date:  2022-03-21       Impact factor: 5.249

6.  Prions and lymphoid organs: solved and remaining mysteries.

Authors:  Tracy O'Connor; Adriano Aguzzi
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

Review 7.  Prion protein-specific antibodies-development, modes of action and therapeutics application.

Authors:  Tihana Lenac Rovis; Giuseppe Legname
Journal:  Viruses       Date:  2014-10-01       Impact factor: 5.048

Review 8.  The role of prion strain diversity in the development of successful therapeutic treatments.

Authors:  Sara A M Holec; Alyssa J Block; Jason C Bartz
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-28       Impact factor: 3.622

9.  Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures.

Authors:  Jeppe Falsig; Tiziana Sonati; Uli S Herrmann; Dino Saban; Bei Li; Karina Arroyo; Boris Ballmer; Pawel P Liberski; Adriano Aguzzi
Journal:  PLoS Pathog       Date:  2012-11-01       Impact factor: 6.823

Review 10.  Role of prion protein aggregation in neurotoxicity.

Authors:  Alessandro Corsaro; Stefano Thellung; Valentina Villa; Mario Nizzari; Tullio Florio
Journal:  Int J Mol Sci       Date:  2012-07-11       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.